Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer

被引:10
|
作者
Cheng, David [1 ,2 ]
Dumontier, Clark [2 ,3 ,4 ]
Sheikh, Ayesha R. [5 ]
La, Jennifer [3 ]
Brophy, Mary T. [3 ,6 ]
Do, Nhan, V [3 ,6 ]
Driver, Jane A. [2 ,3 ,6 ,7 ]
Tuck, David P. [3 ,6 ]
Fillmore, Nathanael R. [2 ,3 ,7 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Dept Med, Boston, MA USA
[3] VA Boston Healthcare Syst, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
[5] St Vincent Hosp, Worcester, MA 01604 USA
[6] Boston Univ, Boston, MA 02215 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
来源
CANCER MEDICINE | 2022年 / 11卷 / 15期
关键词
electronic health records; frailty; non-small cell lung; prognosis; veterans; COMPREHENSIVE GERIATRIC ASSESSMENT; CARE; ONCOLOGY; ACCUMULATION; MORTALITY; CONSENSUS; SURVIVAL; CURVES; ADULTS;
D O I
10.1002/cam4.4658
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Older patients with non-small cell lung cancer (NSCLC) are a heterogeneous population with varying degrees of frailty. An electronic frailty index such as the Veterans Affairs Frailty Index (VA-FI) can potentially help identify vulnerable patients at high risk of poor outcomes. Methods NSCLC patients >= 65 years old and diagnosed in 2002-2017 were identified using the VA Central Cancer Registry. The VA-FI was calculated using administrative codes from VA electronic health records data linked with Medicare and Medicaid data. We assessed associations between the VA-FI and times to mortality, hospitalization, and emergency room (ER) visit following diagnosis by Kaplan-Meier analysis and multivariable stratified Cox models. We also evaluated the change in discrimination and calibration of reference prognostic models after adding VA-FI. Results We identified a cohort of 42,204 older NSCLC VA patients, in which 55.5% were classified as frail (VA-FI >0.2). After adjustment, there was a strong association between VA-FI and the risk of mortality (HR = 1.23 for an increase of four deficits or, equivalently, an increase of 0.129 on VA-FI, p < 0.001), hospitalization (HR = 1.16 for four deficits, p < 0.001), and ER visit (HR = 1.18 for four deficits, p < 0.001). Adding VA-FI to baseline prognostic models led to statistically significant improvements in time-dependent area under curves and did not have a strong impact on calibration. Conclusion Older NSCLC patients with higher VA-FI have significantly elevated risks of mortality, hospitalizations, and ER visits following diagnosis. An electronic frailty index can serve as an accessible tool to identify patients with vulnerabilities to inform clinical care and research.
引用
收藏
页码:3009 / 3022
页数:14
相关论文
共 50 条
  • [31] SPARC expression and prognostic value in non-small cell lung cancer
    Huang, Yan
    Zhang, Jing
    Zhao, Yuan-Yuan
    Jiang, Wei
    Xue, Cong
    Xu, Fei
    Zhao, Hong-Yun
    Zhang, Yang
    Zhao, Li-Ping
    Hu, Zhi-Huang
    Yao, Zhi-Wen
    Liu, Qian-Yong
    Zhang, Li
    CHINESE JOURNAL OF CANCER, 2012, 31 (11) : 541 - 548
  • [32] Comparison of Glasgow prognostic score and prognostic index in patients with advanced non-small cell lung cancer
    Ai-Gui Jiang
    Hong-Lin Chen
    Hui-Yu Lu
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 563 - 568
  • [33] Prognostic and predictive value of HURP in non-small cell lung cancer
    Wang, Qi
    Chen, Yaokun
    Feng, Hui
    Zhang, Biyuan
    Wang, Haiji
    ONCOLOGY REPORTS, 2018, 39 (04) : 1682 - 1692
  • [34] Prognostic value of angiogenesis in operable non-small cell lung cancer
    Giatromanolaki, A
    Koukourakis, M
    OByrne, K
    Fox, S
    Whitehouse, R
    Talbot, DC
    Harris, AL
    Gatter, KC
    JOURNAL OF PATHOLOGY, 1996, 179 (01): : 80 - 88
  • [35] Prognostic value of electronic health records-based frailty measures for all-cause mortality in older patients with non-small cell lung cancer
    Tu, Minh-Thao
    Tran, Thi-Ngoc
    Kwon, Hoejun
    Choi, Yoon-Jung
    Lee, Youngjoo
    Cho, Hyunsoon
    JOURNAL OF GERIATRIC ONCOLOGY, 2025, 16 (01)
  • [36] Prognostic Value of the Geriatric Nutritional Risk Index in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis
    Sun, Xin-Yu
    Lin, Yu
    Guo, Wei
    Yin, Xiao-Ming
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (10): : 3623 - 3633
  • [37] Quantification of the independent prognostic value of Charlson Comorbidity Index among patients with non-small cell lung cancer.
    Meng, Jianfeng
    Zhang, James X.
    Pu, Yonglin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Lung immune prognostic index and survival in patients with non-small cell lung cancer: A systematic review
    Heriyanto, R. S.
    Chrystelle, C.
    Hadisurya, A.
    Tandy, F.
    Suciningtias, M.
    Kurniawan, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S809 - S810
  • [39] Prognostic factors for patients with non-small cell lung cancer
    Rosvold, E
    CURRENT PROBLEMS IN CANCER, 1996, 20 (04) : 272 - 278
  • [40] Biomarker Testing Practices for Non-small Cell Lung Cancer: A Survey of Veterans Affairs Facilities
    Vlachos, E. M.
    Dellitalia, J.
    Rubinstein, I.
    Maurice, N. M.
    Flores, N.
    Tanner, N. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209